FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

QS Violations in Dongguan Rainbow Tech Inspection

FDA warns Chinas Dongguan Rainbow Tech Electronic & Plastics Co. about Quality System Regulation violations in its manufacturing of manual emergency v...

latest-news-card-1
Human Drugs

Report on Ways to Cut Reliance on Foreign Drugs

The Senate Special Committee on Aging releases a report with six recommendations for reducing the use of foreign-made drugs for seniors.

latest-news-card-1
Human Drugs

Makary Details DTC Enforcement Crackdown on Podcast

FDA commissioner Marty Makary addresses during a podcast the agencys significant shift in enforcement policy directed at pharmaceutical advertis...

latest-news-card-1
Human Drugs

FDA Still Finding Issues at Nephron Pharmaceuticals

A South Carolina newspaper reports that the latest FDA inspection at Nephron Pharmaceuticals found the company still has significant quality issues.

Biologics

Moderna Quits CMV Vaccine After Phase 3 Failure

Moderna stops the development of its congenital cytomegalovirus vaccine after it failed to meet the primary endpoint in a large Phase 3 trial.

latest-news-card-1
Human Drugs

3rd Patient-Focused Drug Development Guidance

FDA publishes the third in a series of guidances on aspects of collecting patient experience data to be used in medical product development and regula...

latest-news-card-1
Human Drugs

Major Staff Losses at CDER and CBER Amid Shake-up

FDA releases hiring data showing steep declines in staffing at CDER and CBER.

latest-news-card-1
Human Drugs

CGMP Violations Seen in BRS Services Inspection

FDA warns St. Louis, MO-based BRS Analytical Services about CGMP violations in its production of finished drugs.

latest-news-card-1
Human Drugs

GSK and Speros Antibiotic Positive Phase 3 Results

GSK and Spero Therapeutics report positive Phase 3 results for tebipenem HBr, an investigational oral antibiotic for complicated urinary tract infecti...

latest-news-card-1
Human Drugs

FDA Strengthens Tranexamic Acid Warning

FDA says it is strengthening labeling for tranexamic acid injection products to clarify that it is only to be administered intravenously.